Ranked #1
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9pczUtc3NsLm16c3RhdGljLmNvbS9pbWFnZS90aHVtYi9Db2JhbHRQdWJsaWM2L3Y0L2JhLzdlLzQyL2JhN2U0MjkxLWQ1ZjctZDVlYi0yZGIxLWU0M2MyZmRmMDcxMy9temFfODg2MDIwNzQ0MDk5MTIzMjQ1NC5wbmcvNjAweDYwMGJiLnBuZw==.jpg)
The future management of mantle cell lymphoma
The future management of mantle cell lymphoma
MCL is an aggressive B cell malignancy which is incurable with standard therapies. In this video, the current standard o... Read more
30 Aug 2013
•
16mins
Ranked #2
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9pczItc3NsLm16c3RhdGljLmNvbS9pbWFnZS90aHVtYi9Db2JhbHRQdWJsaWM2L3Y0LzQyLzQzL2RkLzQyNDNkZGNlLWIzNWQtYmY2Yy1hZDJjLWRkZDQxYmVjZmVjYi9temFfMzcyMzU1OTE4NTA5OTczMzM0NS5wbmcvNjAweDYwMGJiLnBuZw==.jpg)
Multiple myeloma: Non-transplant candidates
Multiple myeloma: Non-transplant candidates
Treating elderly MM patients is challenging because of the heterogeneity of this patient population. This needs to be ta... Read more
30 Aug 2013
•
10mins
Similar Podcasts
Ranked #3
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9pczMtc3NsLm16c3RhdGljLmNvbS9pbWFnZS90aHVtYi9Db2JhbHRQdWJsaWMvdjQvMTQvMGYvOTkvMTQwZjk5YmQtZWNiOC0wMjEyLTcwMDUtMjdjNjUzMWY3ZjRiL216YV8yODMxMDQ0MTUyNzExODY5Mjc5LnBuZy82MDB4NjAwYmIucG5n.jpg)
Relapsed multiple myeloma patients
Relapsed multiple myeloma patients
In patients with biochemical relapse with a small increase in M protein levels in the serum or urine, treatment is not i... Read more
30 Aug 2013
•
9mins
Ranked #4
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9pczQtc3NsLm16c3RhdGljLmNvbS9pbWFnZS90aHVtYi9Db2JhbHRQdWJsaWM0L3Y0L2Y0LzZiL2RjL2Y0NmJkY2ZkLTEyZDItYjA2Mi04NWRmLTY5MzI3ODc4NDdhZi9temFfODkxNjM2MzkxMjczMTc5MTEyMi5wbmcvNjAweDYwMGJiLnBuZw==.jpg)
Transplant multiple myeloma candidate
Transplant multiple myeloma candidate
Induction regimen for transplant eligible multiple myeloma (MM) patients is 4-6 course of a triple drug regimen, typical... Read more
30 Aug 2013
•
16mins
Ranked #5
![Podcast cover](https://cdn-images.owltail.com/200x/jpg/aHR0cHM6Ly9pczEtc3NsLm16c3RhdGljLmNvbS9pbWFnZS90aHVtYi9Db2JhbHRQdWJsaWM2L3Y0L2YyL2ZhLzE2L2YyZmExNmQxLWVkNWItNTdkNi0wZDQxLTUzMmZkMDEwYmI1YS9temFfNjUyNDY1MjE2NjI3MTY3MDAyNy5wbmcvNjAweDYwMGJiLnBuZw==.jpg)
Advances in Multiple Myeloma from EHA 2013
Advances in Multiple Myeloma from EHA 2013
Multiple myeloma (MM) is the second most common haematological cancer. There is no cure and the 5-year relative survival... Read more
30 Aug 2013
•
17mins